Click it and Unblock the Notifications
Just In
Don't Miss
-
Robo Shankar's Daughter Indraja Reveals Reason For Thalapathy Vijay's Absence At Her Wedding -
Suzuki Access Electric To Electrify The Indian Scooter Market By 2024 -
Vodafone Idea Shares Soar 7% Following Strong FPO Subscription; GMP Hints Premium Shares; Details -
Infinix GT 20 Pro Schematic Shows Rear Panel Design; Expected to Launch on April 28 -
Chess: Who Is D Gukesh? Profile, Career, Achievements, ILO Rating & Mentor Details of FIDE Candidates Tournament 2024 Winner -
NBSE Nagaland board HSLC, HSSLC result 2024 to be released on April 26 at nbsenl.edu.in, Know more -
What Your Tongue Reveals About Your Health: Wellness And Warning Signs You Need To Know -
Kurnool's Hidden Gems: A Guide To Exploring India's Lesser-Known Treasures
Death fears over 'lizard saliva diabesity' drug
Melbourne, Aug 19 : In the wake of deaths and severe illness among US patients, Australian health authorities can upgrade warnings on Byetta - a new diabetes drug that mimics a hormone found in the saliva of a North American lizard.
According to the US Food and Drug Administration, which has announced tougher warnings on the product, six American patients developed a dangerous form of pancreatitis after taking the medication, and two died.
This comes on top of more than 30 reports of non-fatal pancreas problems among US patients last October.
Australia's Therapeutic Goods Administration (TGA) said relatively few Australians were taking Byetta, which was launched with much fanfare last September but will cost 200 Australian dollars a month until it wins a government subsidy.
However, one case of pancreatitis has been reported in Australia and the regulator is investigating whether it too will tighten warnings.
"The Australian product information currently contains warnings about the potential for pancreatitis to occur with this medicine,'' News.com.au quoted a TGA spokeswoman, as saying.
"The TGA will now review the new information to determine if strengthening of these warnings is required," the rep added.
She urged patients taking Byetta not to suddenly stop treatment but to see their treating doctor if they have concerns.
Byetta is designed as an innovative drug solution for the growing number of people struggling with "diabesity'', the twin scourges of type two diabetes and obesity.
The drug mimics a hormone found in the saliva of a North American lizard which was found to slow the creature's digestion.
It is subsidised in several European countries but the Australian committee charged with PBS approvals has rejected it twice for not demonstrating cost-effective benefits for weight management.
Pharmaceutical company Eli Lilly Australia said it was in discussions with the TGA over the latest reports and said it was continuously monitoring adverse events among patients.
ANI
